Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.
Autor: | Salerno, R. A.1 salernr@wyeth.com, Lesko, L. J.2 leskol@cder.fda.gov |
---|---|
Zdroj: | Pharmacogenomics Journal. 2006, Vol. 6 Issue 2, p78-81. 4p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |